Cardiac arrest & resuscitation

Temperature control after adult cardiac arrest: An updated systematic review and meta-analysis

ResuscitationPublished Systematic review and meta-analysis of controlled trials

An erratum to this article was published (Resuscitation, Jan 2024 ↗)

Authors' conclusion

This updated systematic review showed no benefit of temperature control at 32-34 °C compared to normothermia or 36 °C, although the 95% confidence intervals cannot rule out a potential beneficial effect.

Study context

Population
Adults with cardiac arrest7 trials
Comparison
Temperature control at 32-34 °C vs normothermia or 36 °C
Outcome
Survival and favorable neurological outcome
Follow-up
90-180 days after the cardiac arrest
Methodological detailsupdated systematic review, random-effects models, GRADE, Risk of bias intermediate for most outcomes, Search of PubMed, Embase and CENTRAL on May 31, 2023; six new trials identified
  • Updated systematic review
  • Random-effects models
  • GRADE
  • Risk of bias intermediate for most outcomes
  • Search of PubMed, Embase and CENTRAL on May 31, 2023; six new trials identified

Pooled result

As reported in the abstract

32-34 °C vs Normothermia or 36 °CRelative risk (95% CI)
Survival
1.06(0.91–1.23)
Favorable neurological outcome
1.27(0.89–1.81)

Further pooled results

OutcomeRR (95% CI)
Favorable neurological outcome at any time point (sensitivity analysis, 9 trials)1.14 (0.98–1.34)

Survival and neurological outcome by location of cardiac arrest (in-hospital vs out-of-hospital) (subgroup)

Similar results

Target 31-34 °C, duration 12-24 vs 36 hours, rewarming 0.25-0.5 °C/hour, fever prevention (new individual trials)

No differences in outcomes

Original publication

Temperature control after adult cardiac arrest: An updated systematic review and meta-analysis. Resuscitation. Published 7 August 2023. doi:10.1016/j.resuscitation.2023.109928

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.